Core Viewpoint - The Henan Provincial Government has issued an action plan to accelerate the integration of artificial intelligence in the modern pharmaceutical industry from 2025 to 2027, focusing on enhancing drug research and production efficiency through AI applications [1] Group 1: AI Applications in Pharmaceutical Industry - The plan emphasizes the application of large models in drug intelligent screening, clinical trial design and analysis, and optimization of drug synthesis processes to improve drug R&D efficiency and quality management [1] - It aims to break down barriers between biological data and healthcare data, strengthening the construction and training of traditional Chinese medicine large models to tackle the consistency issues of traditional Chinese medicine products [1] Group 2: AI in Medical Devices - The action plan also promotes the application of AI technology in auxiliary diagnostic testing, brain-machine interfaces, and intelligent rehabilitation for limbs, aiming to enhance the specificity and sensitivity of medical devices [1]

智通财经5月10日电，中国中医科学院10日在京召开中医药交叉学科和智能科学大会，发布中医药大模 型评测标准《面向行业的大规模预训练模型技术和应用评估方法 第12部分：中医药大模型》等多项成 果。在会上了解到，这一标准首次构建了中医药领域大模型量化评估体系。根据这一标准，中医药大模 型评估聚焦技术和应用能力两方面，标准主要覆盖场景丰富度、能力支持度、应用成熟度三大能力域， 13个能力子域，30余个能力项。三大能力域主要关注中医药大模型应用场景的覆盖广度、中医药大模型 的全流程技术能力、中医药大模型在实际应用中的服务质量及效果。 (新华社) 中国中医科学院发布中医药大模型评测标准 ...